FOXA1 and breast carcinoma: MGAT4EP enhances the promoter-binding ability of FOXA1, which, in turn, upregulates the expression of the oncogenic transcription factor FOXM1.18 This indicates that MGAT4EP may play a critical role in the progression of breast cancer.